Версия сайта для людей с нарушением зрения
    шрифт
только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Обычная версия
Раздел 5 / 5
Страница 1 / 1

Список литературы

  1. Boyle ME, Seifert KM, Beer KA, et al. Guidelines for application of continuous subcutaneous insulin infusion (insulin pump) therapy in the perioperative period. J Diabetes Sci Technol. 2012;6(1):184- 190. 3320837.
  2. Guidelines for Medical Necessity Determination for Ambulatory Infusion Pumps (Insulin Pumps). In: MassHealth, ed. Vol MG-IP2011.
  3. Inpatient Guidelines: Insulin Infusion Pump Management. Queensland Health; 2012.
  4. JDRF Position Statement on Insulin Pump Therapy. London: JDRF; 2012.
  5. Evidence Based Guideline: External Insulin Pumps. In: Association BCaBS, ed. North Carolina2013:1-5.
  6. Medical Necessity Guidelines: Continuous Glucose Monitoring System (CGMS). Tufts Health Plan; 2014.
  7. Amod A, Carrihill M, Dave J, et al. Continuous subcutaneous insulin infusion therapy in type 1 diabetes: 2013 clinical guidelines and recommendations from the Association of Clinical Endocrinologists of South Africa (ACE-SA). JEMDSA. 2013;18(1):15-19.
  8. Blevins TC, Bode BW, Garg SK, et al. Statement by the American Association of Clinical Endocrinologists consensus panel on continuous glucose monitoring. Endocr. Pract. 2010;16(5):730- 745. doi: 10.4158/EP.16.5.730.
  9. Cook CB, Boyle ME, Cisar NS, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital setting: Proposed guidelines and outcome measures. Diabetes Educ. 2005;31(6):849-857.
  10. Eugster EA, Francis G. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics. 2006;118(4):e1244-1249. doi: 10.1542/peds.2006-0662.
  11. Excellence NIfHaC. Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus. Technology Appraisal Guidance 151 (Review of Technology Appraisal Guidance 57). London: NICE; 2008.
  12. Francks R. Insulin pump service guidelines for children and young people. Vol SW/CL0057/SOP/v001: NHS; 2013:1-31.
  13. Grunberger G, Bailey TS, Cohen AJ, et al. Statement by the American Association of Clinical Endocrinologists consensus panel on insulin pump management. Endocr. Pract. 2010;16(5):746-762. doi: 10.4158/EP.16.5.746.
  14. Hammond P, Boardman S, Greenwood R. ABCD position paper on insulin pumps. Practical Diabetes International. 2006;23(9):395-400. doi: 10.1002/pdi.1023.
  15. Hammond PJ, Amiel SA, Dayan CM, et al. ABCD position statement on continuous glucose monitoring: use of glucose sensing in outpatient clinical diabetes care. Practical Diabetes International. 2010;27(2):66-68. doi: 10.1002/pdi.1448.
  16. Harrell RM, Orzeck EA, American Association of Clinical Endocrinologists S, Member Advocacy C. Coding guidelines for continuous glucose monitoring. Endocr. Pract. 2010;16(2):151-154. doi: 10.4158/EP.16.2.151.
  17. Klonoff DC, Buckingham B, Christiansen JS, et al. Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2011;96(10):2968-2979. doi: 10.1210/jc.2010-2756.
  18. Liebl A, Henrichs HR, Heinemann L, et al. Continuous Glucose Monitoring: Evidence and Consensus Statement for Clinical Use. J Diabetes Sci Technol. 2013;7(2):500-519. doi: 10.1177/193229681300700227.
  19. McIntyre L. Insulin Pump Therapy for Type 1 Diabetes. 2013.
  20. Morviducci L, Di Flaviani A, Lauria A, et al. Continuous subcutaneous insulin infusion (CSII) in inpatient setting: Unmet needs and the proposal of a csii unit. Diabetes Technology and Therapeutics. 2011;13(10):1071-1074. doi: 10.1089/dia.2011.0056.
  21. Mu Y, Yin S, Chinese Medical Practitioners Association E, Metabolism Branch CSoECDS. Insulin pump therapy guidelines for China (July 2010). Journal of diabetes. 2012;4(2):127-139. doi: 10.1111/j.1753-0407.2011.00174.x.
  22. Phillip M, Battelino T, Rodriguez H, et al. Use of Insulin Pump Therapy in the Pediatric Age-Group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2007;30(6):1653-1662. doi: 10.2337/dc07-9922.
  23. Rodgers J. Using Insulin Pumps in Diabetes: A Guide for Nurses and Other Health Professionals. 2008:222. http://eu.wiley.com/WileyCDA/WileyTitle/productCd-0470059257.html.
  24. Scheiner G, Sobel RJ, Smith DE, et al. Insulin pump therapy guidelines for successful outcomes. Diabetes Educ. 2009;35(2):29S-41S. doi: 10.1177/0145721709333493.
  25. Wilmot EG, Choudhary P, Grant P, Hammond P. Insulin pump therapy: a practical guide to optimising glycaemic control. Practical Diabetes. 2014;31(3):121-125a. doi: 10.1002/pdi.1846.
  26. Дедов ИИ, Петеркова ВА, Кураева ТЛ, et al. Помповая инсулинотерапия сахарного диабета у детей и подростков. Российский консенсус детских эндокринологов. Проблемы эндокринологии. 2012;58(2 выпуск 2):3-18.
  27. Misso ML, Egberts KJ, Page M, et al. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2010(1):CD005103. doi: 10.1002/14651858.CD005103.pub2.
  28. Дедов ИИ, Шестакова МВ, Александров АА, et al. Алгоритмы специализированной медицинской помощи больным сахарным диабетом (5-й выпуск). Сахарный диабет. 2011(3):4- 72.
  29. Pickup J. Insulin Pump Therapy and Continuous Glucose Monitoring. Oxford University Press, Incorporated; 2009.
  30. Wizemann E, Renner R, Hepp K. Prospective evaluation of a standardized basal rate distribution for CSII in type 1 diabetes over 6 months. Diabetologie und Stoffwechsel. 2001;10:57.
  31. Laptev DN, Philippov YI, Emel, et al. Оптимизация настроек инсулиновых помп у детей и подростков с сахарным диабетом 1 типа с учетом возрастных особенностей. Сахарный диабет. 2013(3):109-115. doi: 10.14341/2072-0351-98.
  32. Walsh J, Roberts R, Bailey T. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol. 2010;4(5):1174-1181. 2956816.
  33. Davidson P, Hebblewhite H, Bode B, et al. Statistically based CSII parameters: correction factor, CF (1700 rule), carbohydrate-to-insulin ratio, CIR (2.8 rule), and basal-to-total ratio. Diabetes Technol. Ther. 2003;5(5):A237.
  34. Davidson P, Hebblewhite H, Steed R, Bode B. Analysis of Guidelines for Basal-Bolus Insulin Dosing: Basal Insulin, Correction Factor, and Carbohydrate-to-Insulin Ratio. Endocr. Pract. 2008;14(9):1095-1101.
  35. Walsh J, Roberts R. Pumping Insulin: Everything in a Book for Successful Use of an Insulin Pump. Torrey Pines Press; 1994.
  36. Bode BW. Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine. Endocr. Pract. 2011;17(2):271-280. doi: 10.4158/EP10260.RA.

Для продолжения работы требуется вход / регистрация